Scientists have uncovered dementia-like behavior in pancreas cells at risk of turning into cancer. The findings provide clues ...

Dementia-like protein clumps found in pancreatic precancer mouse cells point to autophagy defects, offering cancer ...

Notoriously hard to treat, pancreatic and colorectal cancers each have high recurrence rates in the years following treatment ...

Berlin: Bayer and Kumquat Biosciences Inc., a clinical-stage biotech company, have announced that they have entered into an ...

The deal – which has a total value of up to $1.3 billion including an unspecified upfront payment – gives Bayer exclusive ...

Bayer partners with Kumquat Biosciences to advance a promising Kras G12D cancer treatment, aiming to address critical unmet ...

Bayer has teamed up with Kumquat Biosciences for a juicy opportunity, committing up to $1.3 billion for the global license to ...

Dr. Zev Wainberg of UCLA recently spoke with CURE about trial results concerning the cancer vaccine ELI-002 2P.

An off-the-shelf cancer vaccine that targets KRAS mutations induced T-cell responses and was associated with impressive ...

Business combination transaction with Helix Acquisition Corp. II, a special purpose acquisition company sponsored by ...

A novel cancer vaccine that stimulates the immune system to target one of the most common cancer-driving mutations has shown ...

New Phase I trial data finds that people who responded to ELI-002 survived longer and stayed cancer-free longer than usual.